LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA
Position in PODD — Insulet Corp
CIK 932974
BOSTON, MA
Position in PODD
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$152,250
-$63,885 QoQ
Shares Held
1,000
-2.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#521
of 716 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PODD Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA holds $508,643,239 across 9 Medical Devices names. PODD ranks #4 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SYK |
Stryker Corp
|
1,154,957 | $363,626,661 | |
| 2 | ABT |
Abbott Laboratories
|
1,566,186 | $142,115,716 | |
| 3 | EW |
Edwards Lifesciences Corp
|
27,447 | $2,482,854 | |
| 4 | PODD |
Insulet Corp
This page
|
1,000 | $152,250 | |
| 5 | GEHC |
GE HealthCare Technologies Inc.
|
1,523 | $97,487 | |
| 6 | MDT |
Medtronic plc
|
975 | $76,274 | |
| 7 | BSX |
Boston Scientific Corp
|
1,233 | $52,624 | |
| 8 | PEN |
Penumbra Inc
|
105 | $33,153 |
All Filings in PODD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $152,250 | 1,000 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $216,135 | 1,030 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $303,284 | 1,067 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $317,991 | 1,030 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $323,605 | 1,030 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $270,488 | 1,030 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $268,902 | 1,030 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $239,732 | 1,030 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $207,854 | 1,030 | Shares | Sole | 2024-07-17 | |
| 2024-03-31 | $176,542 | 1,030 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $223,489 | 1,030 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $164,274 | 1,030 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $288,340 | 1,000 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $318,960 | 1,000 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $294,390 | 1,000 | Shares | Sole | 2023-03-02 | |
| 2022-09-30 | $229,400 | 1,000 | Shares | Sole | 2022-10-25 | |
| 2022-06-30 | $217,940 | 1,000 | Shares | Sole | 2022-07-26 | |
| 2022-03-31 | $266,390 | 1,000 | Shares | Sole | 2022-04-13 | |
| 2021-12-31 | $266,070 | 1,000 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $284,230 | 1,000 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $277,804 | 1,012 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $264,051 | 1,012 | Shares | Sole | 2021-04-14 | |
| 2020-12-31 | $255,630 | 1,000 | Shares | Sole | 2021-01-14 | |
| 2020-09-30 | $236,590 | 1,000 | Shares | Sole | 2020-10-15 | |
| 2020-06-30 | $194,260 | 1,000 | Shares | Sole | 2020-07-30 | |
| 2020-03-31 | $165,680 | 1,000 | Shares | Sole | 2020-04-15 | |
| No filing history on record for this holder in this stock. | ||||||